Shih IM - Search Results

1

Non-Invasive Ultrasound Assessment of Endometrial Cancer Progression in Pax8-Directed Deletion of the Tumor Suppressors Arid1a and Pten in Mice.

Vistein R, Winer B, Myers S, Liberto J, Ishiyama S, Guo X, Saeki H, Wang TL, Shih IM, Gabrielson K. Vistein R, et al. Among authors: shih im. J Vis Exp. 2023 Feb 17;(192). doi: 10.3791/64732. J Vis Exp. 2023. PMID: 36876944

2

Antimotility effects of Chinese herbal medicines on human sperm.

Shih IM, Chiang HS, Yang LL, Wang TL. Shih IM, et al. J Formos Med Assoc. 1990 Jun;89(6):466-9. J Formos Med Assoc. 1990. PMID: 1977862

3

Diagnostic and biological implications of mel-CAM expression in mesenchymal neoplasms.

Shih IM, Wang TL, Westra WH. Shih IM, et al. Clin Cancer Res. 1996 Mar;2(3):569-75. Clin Cancer Res. 1996. PMID: 9816205

4

Intramuscular administration of E7-transfected dendritic cells generates the most potent E7-specific anti-tumor immunity.

Wang TL, Ling M, Shih IM, Pham T, Pai SI, Lu Z, Kurman RJ, Pardoll DM, Wu TC. Wang TL, et al. Among authors: shih im. Gene Ther. 2000 May;7(9):726-33. doi: 10.1038/sj.gt.3301160. Gene Ther. 2000. PMID: 10822298

5

Identifying tumor origin using a gene expression-based classification map.

Buckhaults P, Zhang Z, Chen YC, Wang TL, St Croix B, Saha S, Bardelli A, Morin PJ, Polyak K, Hruban RH, Velculescu VE, Shih IeM. Buckhaults P, et al. Cancer Res. 2003 Jul 15;63(14):4144-9. Cancer Res. 2003. PMID: 12874019

6

Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients.

Wang TL, Diaz LA Jr, Romans K, Bardelli A, Saha S, Galizia G, Choti M, Donehower R, Parmigiani G, Shih IeM, Iacobuzio-Donahue C, Kinzler KW, Vogelstein B, Lengauer C, Velculescu VE. Wang TL, et al. Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):3089-94. doi: 10.1073/pnas.0308716101. Epub 2004 Feb 17. Proc Natl Acad Sci U S A. 2004. PMID: 14970324 Free PMC article.

7

Mutations of BRAF and KRAS precede the development of ovarian serous borderline tumors.

Ho CL, Kurman RJ, Dehari R, Wang TL, Shih IeM. Ho CL, et al. Cancer Res. 2004 Oct 1;64(19):6915-8. doi: 10.1158/0008-5472.CAN-04-2067. Cancer Res. 2004. PMID: 15466181

8

Characterization of active mitogen-activated protein kinase in ovarian serous carcinomas.

Hsu CY, Bristow R, Cha MS, Wang BG, Ho CL, Kurman RJ, Wang TL, Shih IeM. Hsu CY, et al. Clin Cancer Res. 2004 Oct 1;10(19):6432-6. doi: 10.1158/1078-0432.CCR-04-0893. Clin Cancer Res. 2004. PMID: 15475429

9

Apply innovative technologies to explore cancer genome.

Shih IeM, Wang TL. Shih IeM, et al. Curr Opin Oncol. 2005 Jan;17(1):33-8. doi: 10.1097/01.cco.0000147382.97085.e4. Curr Opin Oncol. 2005. PMID: 15608510 Review.

10

Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation.

Singer G, Stöhr R, Cope L, Dehari R, Hartmann A, Cao DF, Wang TL, Kurman RJ, Shih IeM. Singer G, et al. Am J Surg Pathol. 2005 Feb;29(2):218-24. doi: 10.1097/01.pas.0000146025.91953.8d. Am J Surg Pathol. 2005. PMID: 15644779

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

395 results

Search Page

Filters